What is OMGYES.com studying for sexual dysfunction in young adult female cancer survivors?

OMGYES.com is being studied to see how it impacts sexual dysfunction in young adult female cancer survivors. The study aims to evaluate if the web-based program is practical, acceptable, and suitable for participants. University of Chicago leads this research to better understand ways to support survivors' sexual health.

Who may be eligible for this sexual dysfunction clinical trial?

Women aged 18 to 45 years who have been diagnosed with cancer between 15 and 45 years old and have sexual dysfunction may be eligible. Participants must be able to complete online modules and surveys and be in remission at least two months after major treatment. Please review eligibility criteria for more details.

Is there any cost to participate in this sexual dysfunction clinical trial?

Study-related care, including access to the OMGYES.com program and all trial visits, is provided at no cost. However, personal expenses such as travel costs to the clinic may vary and are not guaranteed to be covered. Participants should plan accordingly.

Actively Recruiting

Phase Not Applicable

Age: 18Years - 45Years

FEMALE

ID06868121

Pilot Study of the Web-Based Program OMGYES.com to Support Sexual Health in Young Adult Female Cancer Survivors Aged 18 to 45

Led by University of Chicago · Updated on 2026-06-05

Participants Needed

Research Sites

13 weeks

Total Duration

AI-Summary

What this Trial Is About

Researchers are evaluating the effects of the web-based program OMGYES.com on sexual dysfunction in young adult female cancer survivors. This pilot trial aims to assess how feasible, acceptable, and appropriate the intervention is for this group. The study compares outcomes between participants who receive the intervention immediately and those who begin it after a period of observation. Participants will be assigned to one of two groups an immediate intervention group that starts using OMGYES.com right after enrollment, and a delayed intervention group that undergoes 5 weeks of observation before starting the program. The intervention consists of completing online educational modules at home. During the study, participants will visit the clinic every 5 weeks to complete questionnaires assessing feasibility, acceptability, and appropriateness of the intervention using standardized measures. The main outcome will be measured at the end of the 6-week study period. The trial runs through November 2026 and involves young adult female cancer survivors aged 18 to 45 years.

CONDITIONS

Brief Title

AYA OMGYES Sexual Health Study

Who Can Participate

Age: 18Years - 45Years

FEMALE

Eligibility Criteria

You may qualify if you...

Age 18 to 45 years
Diagnosis of cancer between the ages of 15 and 45
Female genitalia, regardless of gender
Diagnosed with sexual dysfunction
Complete remission and at least two months from a major treatment
Patients with prior or concurrent malignancy that does not interfere with safety or efficacy assessment
Ability to participate in study modules and respond to surveys
Ability to understand and willingness to sign informed consent

You will not qualify if you...

Receiving other investigational agents
Expected to be neutropenic or have a high infection risk excluding vaginal penetration
Unable to complete the study intervention or surveys

Research Team

Cassandra Kuissi, BS

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Pilot Study of the Web-Based Program OMGYES.com to Support Sexual Health in Young Adult Female Cancer Survivors Aged 18 to 45

On this page

AI-Summary

What this Trial Is About

Brief Title

Who Can Participate

Eligibility Criteria

Research Team

Not the Right Trial for You?

On this page

Who Can Participate

Eligibility Criteria